Fieldpoint Private Securities LLC acquired a new position in shares of Icon Plc (NASDAQ:ICLR) in the third quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 2,900 shares of the medical research company’s stock, valued at approximately $330,000.

Several other large investors have also modified their holdings of the stock. Insight Capital Research & Management Inc. acquired a new stake in shares of Icon during the 3rd quarter worth about $1,359,000. Janney Montgomery Scott LLC increased its position in shares of Icon by 11.1% during the 3rd quarter. Janney Montgomery Scott LLC now owns 12,237 shares of the medical research company’s stock worth $1,394,000 after purchasing an additional 1,222 shares during the last quarter. Cubist Systematic Strategies LLC increased its position in shares of Icon by 92.8% during the 3rd quarter. Cubist Systematic Strategies LLC now owns 9,339 shares of the medical research company’s stock worth $1,064,000 after purchasing an additional 4,495 shares during the last quarter. Vident Investment Advisory LLC increased its position in shares of Icon by 248.8% during the 3rd quarter. Vident Investment Advisory LLC now owns 35,263 shares of the medical research company’s stock worth $4,016,000 after purchasing an additional 25,152 shares during the last quarter. Finally, First Republic Investment Management Inc. increased its position in shares of Icon by 22.3% during the 3rd quarter. First Republic Investment Management Inc. now owns 7,988 shares of the medical research company’s stock worth $910,000 after purchasing an additional 1,458 shares during the last quarter. 89.95% of the stock is owned by hedge funds and other institutional investors.

Icon Plc (NASDAQ:ICLR) opened at $113.87 on Thursday. The firm has a market capitalization of $6,104.01, a PE ratio of 21.64, a price-to-earnings-growth ratio of 1.74 and a beta of 0.56. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.90 and a quick ratio of 1.90. Icon Plc has a 52-week low of $73.76 and a 52-week high of $124.48.

Icon (NASDAQ:ICLR) last released its earnings results on Thursday, October 26th. The medical research company reported $1.35 earnings per share for the quarter, beating the consensus estimate of $1.32 by $0.03. The company had revenue of $440.30 million during the quarter, compared to the consensus estimate of $438.09 million. Icon had a return on equity of 28.42% and a net margin of 16.37%. Icon’s revenue was up 4.8% compared to the same quarter last year. During the same period in the previous year, the company posted $1.19 EPS. equities research analysts anticipate that Icon Plc will post 5.37 earnings per share for the current year.

ICLR has been the subject of a number of recent analyst reports. Zacks Investment Research downgraded Icon from a “hold” rating to a “sell” rating in a research report on Wednesday, October 4th. Credit Suisse Group reaffirmed an “outperform” rating and issued a $120.00 target price (up from $105.00) on shares of Icon in a research report on Monday, October 16th. Jefferies Group reaffirmed a “buy” rating and issued a $122.00 target price on shares of Icon in a research report on Tuesday, September 12th. Bank of America began coverage on Icon in a research report on Monday, September 11th. They issued a “buy” rating and a $128.00 target price for the company. Finally, ValuEngine raised Icon from a “hold” rating to a “buy” rating in a research report on Friday, September 1st. Four investment analysts have rated the stock with a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $121.00.

TRADEMARK VIOLATION WARNING: This report was originally published by Watch List News and is owned by of Watch List News. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://www.watchlistnews.com/fieldpoint-private-securities-llc-invests-330000-in-icon-plc-iclr/1762842.html.

About Icon

ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies.

Want to see what other hedge funds are holding ICLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Icon Plc (NASDAQ:ICLR).

Institutional Ownership by Quarter for Icon (NASDAQ:ICLR)

Receive News & Ratings for Icon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Icon and related companies with Analyst Ratings Network's FREE daily email newsletter.